Overview

Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection

Status:
Not yet recruiting

Trial end date:
2022-05-31

Target enrollment:

Participant gender:

Summary

A decentralized, randomized, double-blinded, placebo-controlled, phase 3 clinical efficacy study evaluating nitric oxide nasal spray (NONS) as prevention for treatment of individuals at risk of exposure to COVID-19 infection.

Phase:

Phase 3

Details

Lead Sponsor:

Sanotize Research and Development corp.

Treatments:

Nitric Oxide